Sleep quality outcomes after medical and surgical management of chronic rhinosinusitis.
Endoscopic sinus surgery (ESS) has been shown to improve sleep in patients with chronic rhinosinusitis (CRS). However, it is unknown how this improvement compares with non-CRS control subjects' sleep, and medically treated CRS patients.



Patients meeting diagnostic criteria for CRS and controls from the same reference population were recruited from 4 academic centers. Patients chose either medical or surgical treatment. The Pittsburgh Sleep Quality Index (PSQI) was administered to patients before treatment and after 6 months, whereas controls received the PSQI at enrollment.



The study population consisted of 187 cases (64 medical and 123 surgical) and 101 controls. Baseline PSQI scores for CRS patients (9.27 ± 4.76) were worse than for controls (5.78 ± 3.25), even after controlling for potential confounding factors such as asthma and allergy (p < 0.001). There was no significant difference in baseline PSQI between patients choosing medical vs surgical treatment. The PSQI score in surgical patients improved from 8.36 ± 5.05 to 7.44 ± 5.09 (p = 0.020). The PSQI score in medical patients demonstrated a nonsignificant increase with treatment from 8.71 ± 4.48 to 9.06 ± 4.80 (p = 0.640). After controlling for allergy and asthma, 6-month PSQI scores in medical patients remained significantly higher than in controls (p = 0.001), whereas a significant difference could not be demonstrated between surgical patients and controls (p > 0.05). PSQI subdomain analysis mirrored the overall findings.



Patients with CRS report worse sleep compared with controls. Surgically treated CRS patients show significant improvement in PSQI scores, whereas those continuing with medical management fail to improve and remain worse than controls.
Sinus and Skull Base Surgery Program, Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, UT.
Jeremiah A
JA
Alt
Department of Otolaryngology, University of Colorado, Aurora, CO.
Vijay R
VR
Ramakrishnan
Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, MA.
Michael P
MP
Platt
Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head & Neck Surgery, Medical University of South Carolina, Charleston, SC.
Preeti
P
Kohli
Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head & Neck Surgery, Medical University of South Carolina, Charleston, SC.
Kristina A
KA
Storck
Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head & Neck Surgery, Medical University of South Carolina, Charleston, SC.
Rodney J
RJ
Schlosser
Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head & Neck Surgery, Medical University of South Carolina, Charleston, SC.
Zachary M
ZM
Soler
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004724:Endoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010256:Paranasal Sinuses / Q000601:surgery; D012220:Rhinitis / Q000188:drug therapy* / Q000601:surgery*; D012852:Sinusitis / Q000188:drug therapy* / Q000601:surgery*; D012890:Sleep; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000601:surgery*; D013256:Steroids / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D013256:Steroids
chronic disease; patient-reported outcome measure; quality of life; sinusitis